Earnings Call · Q2 FY2026·2026-07-23

Q2 26EPS +6.85%·Rev n/aQ1 26EPS +6.85%·Rev n/aQ4 25EPS -6.39%·Rev n/aQ3 25EPS +13.56%·Rev n/a⚠ consensus missing

Edwards Lifesciences Corp EW

Gerianne Sarte — Head of Investor Relations

Bernard Zovighian — Chief Executive Officer

Theodora Mistras — Chief Financial Officer

−1.4%1d on move date3d−0.2%5d+3.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more EW calls or request research access.

More EW calls Browse calls Request research access